Guidelines have done more harm than good

Blood Purification

Volumn 26, Issue 1, 2008, Pages 73-76

  Amerling, Richard ^a   Winchester, James F ^a   Ronco, Claudio ^b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Anemia, treatment; Arteriovenous fistula; Compliance; Practice guidelines; Renal bone disease, treatment

Indexed keywords

CALCIUM; HEMOGLOBIN; PARATHYROID HORMONE;

ANEMIA; BONE METABOLISM; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; HEMODIALYSIS PATIENT; HUMAN; KIDNEY DISEASE OUTCOMES QUALITY INITIATIVE; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MEDICAL RESEARCH; MINERAL METABOLISM; NEPHROLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ANEMIA; CALCIFICATION, PHYSIOLOGIC; DIALYSIS; EVIDENCE-BASED MEDICINE; HEALTH CARE SECTOR; HUMANS; KIDNEY FAILURE, CHRONIC; NEPHROLOGY; PRACTICE GUIDELINES AS TOPIC;

EID: 38049079930     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110569     Document Type: Conference Paper

References (21)

1. Amerling R, Winchester JF, Ronco C: Guidelines for Guidelines. Blood Purif 2007;25:36-38.
2. USRDS 2007 Annual Data Report. http://www.usrds.org/2007/pdf/ 06_hosp_morte_07.pdf
3. Ascher E, Gade P, Hingorani A, Mazzariol F, Gunduz Y, Fodera M, Yorkovich W: Changes in the practice of angioaccess surgery: impact of dialysis outcome and quality initiative recommendations. J Vasc Surg 2000;31:84-92.
4. Lacson E Jr, Lazarus JM, Himmelfarb J, Ikizler TA, Hakim RM: Balancing fistula first with catheters last. Am J Kidney Dis 2007;50:379-395.
5. MacRae JM, Pandeya S, Humen DP, Krivitski N, Lindsay RM: Arteriovenous fistula-associated high-output cardiac failure: a review of mechanisms. Am J Kidney Dis 2004;43:e17-e22.
6. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006;47(suppl 3):S11-S145.
7. Singh AK, Szczech L, Tang KL, et al: Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006;355:2085-2098.
8. Drüeke TB, Locatelli F, Clyne N, et al: Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006;355:2071-2084.
9. Armstrong D: Medical Journal Spikes Article on Industry Ties of Kidney Group. The Wall Street Journal, B1, December 26, 2006.
10. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis, Vol 28, 1996:53-61.
11. Jones M, Ibels L, Schenkel B, Zagari M: Impact of epoetin alfa on clinical end points in patients with chronic renal failure: a metaanalysis. Kidney Int 2004;65:757-767.
12. Strippoli GFM, Craig JC, Manno C, Schena FP: Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials. J Am Soc Nephrol 2004;15:3154-3165.
13. Besarab A, Bolton WK, Browne JK, et al: The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998;339:584-590.
14. Coyne DW: Influence of industry on renal guideline development. Clin J Am Soc Nephrol 2007;2:3-7.
15. KDOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis Oct 2003;42(suppl 3):1-202.
16. Chertow GM, Burke SK, Raggi P: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002;62:245-252.
17. Block GA, Raggi P, Bellasi A, et al: Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007;71:802-807.
18. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, Vernejoule MC: Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 2004;15:1943-1951.
19. Slatopolsky E, Finch J, Clay P, Martin D, Sicard G, Singer G, Gao P, Cantor T, Dusso A: A novel mechanism for skeletal resistance in uremia. Kidney Int 2000;58:753-761.
20. Faugere M-C, Geng Z, Mawad H, et al: Improved assessment of bone turnover by the PTH 1-84/large C-PTH fragments ratio in ESRD patients. Kidney Int 2001;60:1460-1468.
21. Qi Q, Monier-Faugere MC, Geng Z, Malluche HH: Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis 1995;26:622-631.